Persistent remission of severe rheumatoid arthritis associated with myelodysplastic syndrome upon treatment with lenalidomide

•Individuals with a history of autoimmune diseases, including RA, have an increased risk of developing MDS.•Patient with long-standing, severe and refractory RA who developed MDS achieved remission of both conditions with Lenalidomide.•Lenalidomide might be an effective option for concurrent RA with...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Joint, bone, spine : revue du rhumatisme bone, spine : revue du rhumatisme, 2024-05, Vol.91 (3), p.105693, Article 105693
Hauptverfasser:	Carvès, Sandrine, Birsen, Rudy, Avouac, Jérôme
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Arthritis, Rheumatoid - complications Arthritis, Rheumatoid - drug therapy Female Humans Lenalidomide Lenalidomide - therapeutic use Male Middle Aged Myelodysplastic syndrome Myelodysplastic Syndromes - complications Myelodysplastic Syndromes - drug therapy Remission Induction - methods Rheumatoid arthritis Severity of Illness Index Thalidomide - analogs & derivatives Thalidomide - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	•Individuals with a history of autoimmune diseases, including RA, have an increased risk of developing MDS.•Patient with long-standing, severe and refractory RA who developed MDS achieved remission of both conditions with Lenalidomide.•Lenalidomide might be an effective option for concurrent RA with MDS.
ISSN:	1297-319X 1778-7254 1778-7254
DOI:	10.1016/j.jbspin.2024.105693